Search clinical trials for: Acalabrutinib Treatment C

Total 14581 results

Acerta Pharma BV

Active, not recruiting

A Study of ACP-196 (Acalabrutinib) in Subjects With Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy

Chronic Lymphocytic Leukemia

United States, United Kingdom, Belgium, Spain, Israel, France
Acerta Pharma BV

Withdrawn

A Study of Acalabrutinib in Combination With Rituximab Versus Ibrutinib Versus Acalabrutinib in Subjects With Relapsed or Refractory Mantle Cell Lymphoma

Mantle Cell Lymphoma
University of Texas at Austin

Active, not recruiting

Implementing HCV Treatment for High-risk Populations in Austin, Texas

Hepatitis C Virus Infection

United States
Institute of Liver and Biliary Sciences, India

Completed

Efficacy of Vitamin C on AKI Outcomes in Critically Ill Cirrhotics With Multidrug-resistant Bacterial Infections.

Liver Cirrhosis

India
University of California, Berkeley

Active, not recruiting

Implementing and Sustaining a Sleep Treatment to Improve Community Mental Health Part 2: Train-the-Trainer

Sleep Disorder | Circadian Dysregulation

United States
University Hospital, Caen

Completed

HEMOTOL: Efficacy and Safety of Hemodialysis On-line Monitoring Devices on Hemodynamic Stability in Intensive Care Unit (HEMOTOL)

Hemodialysis

France
Acerta Pharma BV

Active, not recruiting

A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)

Glioblastoma Multiforme

United States
University of California, Berkeley

Recruiting

Implementing and Sustaining a Sleep Treatment to Improve Community Mental Part 1: Implementation Health Outcomes

Sleep Disorder | Circadian Dysregulation

United States
AstraZeneca
Parexel

Completed

A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and Formoterol

Chronic Obstructive Pulmonary Disease (COPD)

United States
Dr. Reddy's Laboratories Limited

Completed

Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches

Migraine

United States
Postgraduate Institute of Dental Sciences Rohtak

Unknown

Comparision of Non Surgical Retreatment and Endodontic Surgery of Failed Root Canal Treated Teeth

Periapical Periodontitis | Root Canal Therapy

India
University of Alabama at Birmingham

Not yet recruiting

Study of Tazemetostat in Lymphoid Malignancies

T-cell Lymphoma

United States
AstraZeneca
UKCLL Forum

Recruiting

Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United Kingdom (EPIC)

Chronic Lymphocytic Leukemia, CLL

United Kingdom
Dana-Farber Cancer Institute

Recruiting

Acalabrutinib in CNSL

Refractory Central Nervous System Lymphoma | Central Nervous System Lymphoma | Recurrent Central Nervous System Lymphoma

United States
Acerta Pharma BV
AstraZeneca

Terminated

Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19

COVID-19

Brazil
Acerta Pharma BV

Completed

A Study to Evaluate the Effect of Hepatic Insufficiency on the Pharmacokinetics (PK) of ACP-196

Hepatic Insufficiency

United States
Hospital Universitari de Bellvitge

Completed

Study of Two Techniques of Rectal Reservoir in Low Anterior Resection of Rectum

Low Rectal Adenocarcinoma
AstraZeneca
Merck Sharp & Dohme LLC; Iqvia Pty Ltd

Completed

A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours. (IVIVC)

Malignant Solid Tumor

Belgium
Johns Hopkins University
AstraZeneca

Completed

Preventing Anaphylaxis With Acalabrutinib

Food Allergy | Food Allergy Peanut

United States
Weill Medical College of Cornell University
AstraZeneca

Withdrawn

Early Intervention With Acalabrutinib in Patients With High Risk CLL

Chronic Lymphocytic Leukemia | CLL/SLL

United States
Cerevel Therapeutics, LLC

Recruiting

A Study Evaluating the Pharmacokinetics and Relative Bioavailability of Emraclidine Immediate-Release Tablets in Healthy Adult Participants

Healthy Participants

United States
Polish Lymphoma Research Group
AstraZeneca

Active, not recruiting

Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT) (ACALLO)

Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Adverse Event | Chronic Graft-versus-host-disease | Response Rate

Poland
University of Roma La Sapienza

Completed

Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients (RBV)

Hepatitis C

Italy
Ulthera, Inc

Completed

Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment

Scars | Striae

United States
University of Sao Paulo General Hospital

Unknown

Project Arthritis Recovering Quality of Life Through Education 70+ (PARQVE)

Knee Osteoarthritis

Brazil
Judge Baker Children's Center
University of Illinois at Chicago; University of Hawaii; MacArthur Foundation

Completed

The Clinic Treatment Project (CTP)

Depression | Problem Behavior | Anxiety

United States
International Extranodal Lymphoma Study Group (IELSG)

Active, not recruiting

Study of Acalabrutinib and Tafasitamab in MZL Patients

Marginal Zone Lymphoma

Italy, Switzerland, Austria
AstraZeneca
Parexel

Not yet recruiting

A Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) Hydrofluoroolefin (HFO) With a Spacer (Treatment B), BGF MDI Hydrofluoroalkane (HFA) With a Spacer (Treatment A), as Well as BGF MDI HFO Without a Spacer (Treatment C)

Healthy

Germany
ANRS, Emerging Infectious Diseases

Completed

A Community-based Intervention Among Active Drug Users in Montpellier (ICONE)

Drug Use | HCV Infection

France
Epividian
Gilead Sciences; AIDS Healthcare Foundation

Completed

Hepatitis C Diagnosis to Treatment Management

Hepatitis C

United States
AstraZeneca

Recruiting

A Study to Assess the Pharmacokinetics and Safety of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) Hydrofluoroolefin (HFO) With a Spacer (Treatment B), BGF MDI Hydrofluoroalkane (HFA) With a Spacer (Treatment A), as Well as BGF MDI HFO Without a Spacer (Treatment C).

Chronic Obstructive Pulmonary Disease

Germany, United Kingdom
Istanbul University - Cerrahpasa (IUC)

Not yet recruiting

The Effect of Motor Imagery in Patients With Radius Distal End Fracture

Distal Radius Fracture
University Health Network, Toronto

Active, not recruiting

Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma

Mantle Cell Lymphoma

Canada
Acerta Pharma BV

Active, not recruiting

Acalabrutinib in Combination With ACP-319, for Treatment of Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
Nordic Lymphoma Group
AstraZeneca

Active, not recruiting

Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma (ALTAMIRA)

Mantle Cell Lymphoma | MCL

Finland, Sweden, Norway, Denmark, Korea, Republic of
Alimentiv Inc.
Takeda Development Center Americas, Inc.

Recruiting

Determination of the Optimal Treatment Target in Ulcerative Colitis (VERDICT)

Colitis, Ulcerative

Canada, United Kingdom, Poland, Italy, United States, Belgium, France, Netherlands, Belarus, Ukraine
Pfizer
Arvinas Estrogen Receptor, Inc.

Recruiting

A Study to Learn How Various Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood of Healthy Adults

Healthy

United States
IlDong Pharmaceutical Co Ltd

Completed

A Drug Interaction Study of Cilnidipine and Valsartan

Healthy

Korea, Republic of
Region Skane
Lund University

Recruiting

ACUTE-Acute Surgical Care- Risk Factors and Outcomes for Patients in Need of Acute Surgical Care (ACUTE)

Complication of Surgical Procedure | Risk Factors | Complication of Treatment | Complication of Anesthesia | Long Term Effects After Emergency Surgery | Long Term Effects After GI Bleeding

Sweden
Sahlgrenska University Hospital, Sweden

Recruiting

Local Recurrence Due to Rectal Cancer in Sweden (LERIS)

Rectal Neoplasms

Sweden
Janssen R&D Ireland

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2336805 Alone and With the Co-administration of TMC435 in Healthy Japanese Participants.

Healthy

United States
Acerta Pharma BV

Active, not recruiting

A Study of AZD6738 and Acalabrutinib in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

United Kingdom, Poland
National Institute of Allergy and Infectious Diseases...

Completed

A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)

HIV Infections

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Bioequivalence Study of 2 Formulations of Rabeprazole Sodium and Evaluation of the Effect of Food on Rabeprazole Sodium in Healthy Adult Volunteers

Healthy
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Relative Bioavailability Study of Rabeprazole Sodium Administered With Different Dosing Vehicles in Healthy Adult Volunteers

Healthy
Acerta Pharma BV

Completed

A Study to Evaluate the Effect of Gastric pH on Acalabrutinib Pharmacokinetics (PK) in Healthy Adult Participants

Healthy Volunteers

United States
University of Illinois at Chicago
National Heart, Lung, and Blood Institute (NHLBI)

Completed

A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities (AHEAD2)

Hypertension
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers

Hypertension | Dyslipidemias

Korea, Republic of
AstraZeneca

Completed

Study to Collect Samples for MIST Analysis of Zibotentan and Bioavailability of Zibotentan and Dapagliflozin in Heatlhy Participants

Chronic Kidney Disease

United States
Inhye Ahn
Bayer

Withdrawn

Copanlisib Plus Ibrutinib or Acalabrutinib in R/R CLL

Chronic Lymphocytic Leukemia (CLL)

3

Subscribe